Back to search
Internuclear Ophthalmoplegia
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Internuclear Ophthalmoplegia trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Internuclear Ophthalmoplegia trials you may qualify forInternuclear ophthalmoplegia is a symptom frequently associated with multiple sclerosis (MS), although other etiologies are possible. Some patients do not meet…
Rationale: Clemastine fumarate has been identified as potential remyelinating therapy for multiple sclerosis (MS). The (long-term) effects of clemastine need to…
The goal of this observational study is to study the relationship between cognitive problems and problems in eye movements in Multiple Sclerosis (MS). The main…